Sexual Well-Being Among Partnered Women With Breast Cancer Recurrence

Por Andersen, Barbara L., Carpenter, Kristen M., Yang, Hae-Chung, Shapiro, Charles L.
Publicado em 2007

Surviving Recurrence: Psychological and Quality-of-life Recovery

Por Yang, Hae-Chung, Thornton, Lisa M., Shapiro, Charles L., Andersen, Barbara L.
Publicado em 2008

Child Maltreatment and Breast Cancer Survivors: Social Support Makes a Difference for Quality of Life, Fatigue, and Cancer Stress

Por Fagundes, Christopher P., Lindgren, Monica E., Shapiro, Charles L., Kiecolt-Glaser, Janice K.
Publicado em 2012

Identifying survival associated morphological features of triple negative breast cancer using multiple datasets

Por Wang, Chao, Pécot, Thierry, Zynger, Debra L, Machiraju, Raghu, Shapiro, Charles L, Huang, Kun
Publicado em 2013

Differential anti-proliferative activities of poly(ADP-ribose) polymerase (PARP) inhibitors in triple-negative breast cancer cells

Por Chuang, Hsiao-Ching, Kapuriya, Naval, Kulp, Samuel K., Chen, Ching-Shih, Shapiro, Charles L.
Publicado no Breast Cancer Res Treat (2012)

Psychological Responses to Cancer Recurrence: A Controlled Prospective Study

Por Andersen, Barbara L., Shapiro, Charles L., Farrar, William B., Crespin, Timothy, Wells-DiGregorio, Sharla
Publicado em 2005

Delayed Emotional Recovery After Taxane-based Chemotherapy

Por Thornton, Lisa M., Carson, William E., Shapiro, Charles L., Farrar, William B., Andersen, Barbara L.
Publicado em 2008

Treatment-Related Mortality With Everolimus in Cancer Patients

Por Wesolowski, Robert, Abdel-Rasoul, Mahmoud, Lustberg, Maryam, Paskell, Maria, Shapiro, Charles L., Macrae, Erin R.
Publicado em 2014

Phase II Trial of Exemestane in Combination With Fulvestrant in Postmenopausal Women With Advanced, Hormone-Responsive Breast Cancer

Por Mrózek, Ewa, Layman, Rachel, Ramaswamy, Bhuvaneswari, Schaaf, Larry, Li, Xiaobai, Ottman, Susan, Shapiro, Charles L.
Publicado no Clin Breast Cancer (2012)

Hedgehog Signaling Is a Novel Therapeutic Target in Tamoxifen-Resistant Breast Cancer Aberrantly Activated by PI3K/AKT Pathway

Por Ramaswamy, Bhuvaneswari, Lu, Yuanzhi, Teng, Kun-yu, Nuovo, Gerard, Li, Xiaobai, Shapiro, Charles L., Majumder, Sarmila
Publicado em 2012

Phase II Trial of Neoadjuvant Weekly Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Biweekly Bevacizumab Therapy in Women With Clinical Stage II or III HER2-Negative Breas...

Por Mrózek, Ewa, Layman, Rachel, Ramaswamy, Bhuvaneswari, Lustberg, Maryam, Vecchione, Andrea, Knopp, Michael V., Shapiro, Charles L.
Publicado em 2014

Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer

Por Oostra, Drew R., Lustberg, Maryam B., Reinbolt, Raquel E., Pan, Xueliang, Wesolowski, Robert, Shapiro, Charles L.
Publicado no Mol Cell Endocrinol (2015)

Epigenetic Repression of RARRES1 Is Mediated by Methylation of a Proximal Promoter and a Loss of CTCF Binding

Por Peng, Zhengang, Shen, Rulong, Li, Ying-Wei, Teng, Kun-Yu, Shapiro, Charles L., Lin, Huey-Jen L.
Publicado em 2012

Feasibility of stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction

Por Berger, Michael J., Dunlea, Leslie J., Rettig, Amy E., Lustberg, Maryam B., Phillips, Gary S., Shapiro, Charles L.
Publicado em 2011

Are rural Ohio Appalachia cancer survivors needs different than urban cancer survivors?

Por Katz, Mira L., Reiter, Paul L., Corbin, Sandy, de Moor, Janet S., Paskett, Electra D., Shapiro, Charles L.
Publicado em 2010

MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27(Kip1)

Por Miller, Tyler E., Ghoshal, Kalpana, Ramaswamy, Bhuvaneswari, Roy, Satavisha, Datta, Jharna, Shapiro, Charles L., Jacob, Samson, Majumder, Sarmila
Publicado em 2008

Risk factors for anthracycline-associated cardiotoxicity

Por Reinbolt, Raquel E., Patel, Roshan, Pan, Xueliang, Timmers, Cynthia Dawn, Pilarski, Robert, Shapiro, Charles L., Lustberg, Maryam B.
Publicado no Support Care Cancer (2015)

Fhit, Wwox and AP2γ expression levels correlate with basal phenotype in breast cancer

Por Guler, Gulnur, Huebner, Kay, Himmetoglu, Cigdem, Jimenez, Rafael E., Costinean, Stefan, Volinia, Stefano, Pilarski, Robert T., Hayran, Mutlu, Shapiro, Charles L.
Publicado em 2009

Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review

Por Poi, Ming J., Berger, Michael, Lustberg, Maryam, Layman, Rachel, Shapiro, Charles L., Ramaswamy, Bhuvaneswari, Mrozek, Ewa, Olson, Erin, Wesolowski, Robert
Publicado em 2013

Induction of ATM/ATR pathway combined with Vγ2Vδ2 T cells enhance cytotoxicity of ovarian cancer cells

Por Lu, Jingwei, Das, Manjusri, Kanji, Suman, Aggarwal, Reeva, Joseph, Matthew, Ray, Alo, Shapiro, Charles L., Pompili, Vincent J., Das, Hiranmoy
Publicado em 2014